ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors
出版年份 2014 全文链接
标题
ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors
作者
关键词
-
出版物
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 171, Issue 3, Pages R91-R99
出版商
Bioscientifica
发表日期
2014-05-16
DOI
10.1530/eje-14-0198
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Thyroid Hormone Inactivation in Gastrointestinal Stromal Tumors
- (2014) Michelle A. Maynard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Authentic Bosutinib Inhibits Triiodothyronine Transport by Monocarboxylate Transporter 8
- (2014) Doreen Braun et al. THYROID
- Case of Sorafenib-Induced Thyroid Storm
- (2013) Sigurdis Haraldsdottir et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
- (2013) Robert J Motzer et al. LANCET ONCOLOGY
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib
- (2012) Julia Clemons et al. Clinical Genitourinary Cancer
- Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study
- (2012) Sandra Feldt et al. EUROPEAN JOURNAL OF CANCER
- Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial
- (2012) T C Schneider et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Sorafenib therapy decreases the clearance of thyrotropin
- (2012) Herman Verloop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer
- (2012) Egidio Del Fabbro et al. JOURNAL OF CHEMOTHERAPY
- Severe hypothyroidism presenting as myxedema coma in the postoperative period in a patient taking sunitinib: case report and review of literature
- (2012) Abhijit V. Lele et al. JOURNAL OF CLINICAL ANESTHESIA
- Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
- (2012) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Inappropriate Elevation of Serum Thyrotropin Levels in Patients Treated with Axitinib
- (2012) Kenji Ohba et al. THYROID
- Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
- (2011) R. Sabatier et al. ANNALS OF ONCOLOGY
- Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population
- (2011) Merina Ahmed et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia
- (2011) Tetsuichi Yoshizato et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
- (2011) Maryse Brassard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sunitinib-Induced Hypothyroidism Is due to Induction of Type 3 Deiodinase Activity and Thyroidal Capillary Regression
- (2011) Mariëtte H. W. Kappers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tyrosine Kinase Inhibitors Noncompetitively Inhibit MCT8-Mediated Iodothyronine Transport
- (2011) Doreen Braun et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Richard H. de Boer et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2011) Ronald B. Natale et al. JOURNAL OF CLINICAL ONCOLOGY
- Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
- (2011) Hagop M Kantarjian et al. LANCET ONCOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib Induced Thyroiditis in Two Patients with Hepatocellular Carcinoma
- (2011) Leni van Doorn et al. THYROID
- Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Bruce G. Robinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination
- (2010) Randa M. Abdulrahman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial
- (2010) Roy S Herbst et al. LANCET ONCOLOGY
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- The tricyclic antidepressant desipramine inhibits T3 import into primary neurons
- (2010) Stephan Roth et al. NEUROSCIENCE LETTERS
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Shrinkage of Thyroid Volume in Sunitinib-Treated Patients with Renal-Cell Carcinoma: A Potential Marker of Irreversible Thyroid Dysfunction?
- (2010) Aljosja Rogiers et al. THYROID
- Sunitinib Induces Hypothyroidism with a Markedly Reduced Vascularity
- (2010) Noriko Makita et al. THYROID
- Sorafenib-Induced Destructive Thyroiditis
- (2010) Massimo Iavarone et al. THYROID
- Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
- (2010) Theo D. Kim et al. THYROID
- Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib
- (2010) L. M. Riesenbeck et al. WORLD JOURNAL OF UROLOGY
- Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
- (2009) Hendrieke Hoftijzer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
- (2008) P Wolter et al. BRITISH JOURNAL OF CANCER
- Thyrotoxicosis during sunitinib treatment for renal cell carcinoma
- (2008) Mathis Grossmann et al. CLINICAL ENDOCRINOLOGY
- Lack of imatinib-induced thyroid dysfunction in a cohort of non-thyroidectomized patients
- (2008) José Miguel Dora et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenes and Cancer
- (2008) Carlo M. Croce NEW ENGLAND JOURNAL OF MEDICINE
- Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
- (2007) I. Tamaskar et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started